Skip to main content

CAH

Stock

CAH

Stock
Health Care
Medical Distribution

Performance overview

CAH Price
Price Chart

Forward-looking statistics

Beta
0.32
Risk
22.14%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Cardinal Health is one of three leading pharmaceutical wholesalers in the U.S., engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and McKesson, the three comprise well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

Company info

SectorHealth Care
IndustryMedical Distribution
Employees39K
Market cap$24.0B

Fundamentals

Enterprise value$45.5B
Revenue$222.3B
Revenue per employee—
Profit margin0.70%
Debt to equity-4.05

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)$6.38
Dividend per share$2.02
Revenue per share$915.70
Avg trading volume (30 day)$361M
Avg trading volume (10 day)$470M
Put-call ratio—

Macro factor sensitivity

Growth+1.7
Credit+1.1
Liquidity+0.8
Inflation-1.2
Commodities+0.0
Interest Rates-0.4

Valuation

Dividend yield1.23%
PEG Ratio19.09
Price to sales0.18
P/E Ratio19.09
Enterprise Value to Revenue0.20
Price to book-20.86

Upcoming events

Next earnings dayMay 1, 2025
Next dividend day—
Ex. dividend dayJuly 1, 2025

News

Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors

In the closing of the recent trading day, Cardinal Health (CAH) stood at $162.17, denoting a -1.27% move from the preceding trading day.

Zacks Investment Research (July 10, 2025)
5 Must-Watch Stocks Favored by Brokers as 2H25 Begins

Brokers are bullish on CBRL, BGSF, ARCB, CAH and AN as improving estimates and value metrics signal strength for 2H25.

Zacks Investment Research (July 1, 2025)
Cardinal Health Analyst Flags Fading Scale Gap, Sees Rising Edge in Specialty Growth

BofA Securities analyst Allen Lutz reiterated the Buy rating on Cardinal Health, Inc. CAH, raising the price forecast from $165 to $170.

Benzinga (June 11, 2025)
Cramer's Stop Trading: Cardinal Health

Jim Cramer breaks down why he's keeping an eye on shares of Cardinal Health.

CNBC Television (June 10, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free